PATJ and nonpapillary renal cell carcinoma: In addition, the SurExpress database data showed that levels of PATJ was low in high-risk ccRCC patients using COX regression analysis (n = 468; p = 1.1e-05; CI = 64.4; HR = 2.1; Figure 3C), while a bioinformatic analysis of PATJ expression in 46 patients with kidney transplants using the GSE22229 data set showed a significant decrease in PATJ mRNA in standard immunotherapeutic tissues compared with tolerant tissues (p = 0.020; Figure 3D), indicating that patients with high PATJ expression were more tolerant to kidney transplantation.